XML 31 R19.htm IDEA: XBRL DOCUMENT
v3.26.1

STOCK WARRANTS | 3 Months Ended
--- | ---
Mar. 31, 2026
Stock Warrants |
STOCK WARRANTS | 10. STOCK WARRANTS The Company has the following warrants outstanding as of March 31, 2026, all of which are exercisable: SCHEDULE OF WARRANTS OUTSTANDING
|  | Warrants |  |  | Weighted- Average Exercise Price |  |  | Weighted- Average Remaining Contractual Life (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at January 1, 2026 |  |  | 1,681,392 |  |  | $ | 3.23 |  |  |  | N/A |  |  | $ | 3,339 |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at March 31, 2026, all vested |  |  | 1,681,392 |  |  | $ | 3.23 |  |  |  | N/A |  |  | $ | 4,144 |
At March 31, 2026, the intrinsic value of the outstanding warrants was $4,144. In connection with the PIPE offering that occurred in 2025, pre-funded warrants were granted to purchase up to an aggregate of 1,677,996 shares of Common Stock at a purchase price per warrant of $9.5099. Each of the pre-funded warrants is exercisable for one share of Common Stock at the exercise price of $0.0001 per pre-funded warrant share, immediately exercisable, and may be exercised at any time until all of the pre-funded warrants issued in the PIPE are exercised in full. There is no expiration date or contractual life associated with the pre-funded warrants and therefore, the weighted-average remaining contractual life cannot be calculated.

X
- References No definition available. + Details
Name: | TONX_DisclosureStockWarrantsAbstract
Namespace Prefix: | TONX_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Stock Warrants [Text Block] + References No definition available. + Details
Name: | TONX_StockWarrantsTextBlock
Namespace Prefix: | TONX_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration